Dual targeting of VEGF and PD-1: A phase I/II trial of ivonescimab, a novel bispecific antibody, in recurrent glioblastoma.

Authors: Anuj Dilip Patel, Ashley Aaroe, Carlos Kamiya-Matsuoka, Ruitao Lin, Nazanin Majd, Barbara Jane O'Brien, Chirag B. Patel, Shiao-Pei S. Weathers, Vinay K. Puduvalli

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2101

Source: Full article

---

Abstract

TPS2101